The pathobiologic implications for treatment: Old and new strategies in the treatment of chronic asthma

T. Horiuchi; M. Castro

doi:10.1016/S0272-5231(05)70273-2

The pathobiologic implications for treatment: Old and new strategies in the treatment of chronic asthma

T. Horiuchi
, M. Castro

Division of Pulmonary & Critical Care Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

An increased understanding of the pathobiology of asthma has led to improved treatment for chronic asthma. This article discusses the old and new strategies of asthma therapy based on a pathobiologic approach. Therapeutic agents discussed include β-adrenergic agonists, methylxanthines, corticosteroids, cromolyn, nedocromil, leukotriene modifiers, and new investigational agents.

Original language	English
Pages (from-to)	381-395
Number of pages	15
Journal	Clinics in Chest Medicine
Volume	21
Issue number	2
DOIs	https://doi.org/10.1016/S0272-5231(05)70273-2
State	Published - 2000

Access to Document

10.1016/S0272-5231(05)70273-2

Cite this

@article{928abeb7bb6d4b458385a49f1c9f71e8,

title = "The pathobiologic implications for treatment: Old and new strategies in the treatment of chronic asthma",

abstract = "An increased understanding of the pathobiology of asthma has led to improved treatment for chronic asthma. This article discusses the old and new strategies of asthma therapy based on a pathobiologic approach. Therapeutic agents discussed include β-adrenergic agonists, methylxanthines, corticosteroids, cromolyn, nedocromil, leukotriene modifiers, and new investigational agents.",

author = "T. Horiuchi and M. Castro",

year = "2000",

doi = "10.1016/S0272-5231(05)70273-2",

language = "English",

volume = "21",

pages = "381--395",

journal = "Clinics in Chest Medicine",

issn = "0272-5231",

number = "2",

}

TY - JOUR

T1 - The pathobiologic implications for treatment

T2 - Old and new strategies in the treatment of chronic asthma

AU - Horiuchi, T.

AU - Castro, M.

PY - 2000

Y1 - 2000

N2 - An increased understanding of the pathobiology of asthma has led to improved treatment for chronic asthma. This article discusses the old and new strategies of asthma therapy based on a pathobiologic approach. Therapeutic agents discussed include β-adrenergic agonists, methylxanthines, corticosteroids, cromolyn, nedocromil, leukotriene modifiers, and new investigational agents.

AB - An increased understanding of the pathobiology of asthma has led to improved treatment for chronic asthma. This article discusses the old and new strategies of asthma therapy based on a pathobiologic approach. Therapeutic agents discussed include β-adrenergic agonists, methylxanthines, corticosteroids, cromolyn, nedocromil, leukotriene modifiers, and new investigational agents.

UR - https://www.scopus.com/pages/publications/0033932811

U2 - 10.1016/S0272-5231(05)70273-2

DO - 10.1016/S0272-5231(05)70273-2

M3 - Article

C2 - 10907595

AN - SCOPUS:0033932811

SN - 0272-5231

VL - 21

SP - 381

EP - 395

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

IS - 2

ER -

The pathobiologic implications for treatment: Old and new strategies in the treatment of chronic asthma

Abstract

Access to Document

Other files and links

Fingerprint

Cite this